Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089063017 | Ceftaroline fosamil acetic acid solvate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5089064011 | Ceftaroline fosamil acetic acid solvate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5606951000052113 | ceftarolinfosamilättiksyrasolvat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ceftaroline fosamil acetic acid solvate (substance) | Is a | Cephalosporin (substance) | true | Inferred relationship | Some | ||
| Ceftaroline fosamil acetic acid solvate (substance) | Has disposition (attribute) | Antibacterial (disposition) | true | Inferred relationship | Some | ||
| Ceftaroline fosamil acetic acid solvate (substance) | Is modification of (attribute) | Ceftaroline (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has precise active ingredient | True | Ceftaroline fosamil acetic acid solvate (substance) | Inferred relationship | Some | 1 |
| Ceftaroline fosamil acetic acid solvate monohydrate (substance) | Is modification of (attribute) | True | Ceftaroline fosamil acetic acid solvate (substance) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR